(Q36330568)

13 August 2017

Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis (English)

1 reference

13 August 2017

0 references

Michael W Konstan

1

1 reference

13 August 2017

Mark D Schluchter

series ordinal

2

1 reference

13 August 2017

Wei Xue

series ordinal

3

1 reference

13 August 2017

Pamela B Davis

series ordinal

4

1 reference

13 August 2017

language of work or name

English

0 references

publication date

13 September 2007

1 reference

American Journal of Respiratory and Critical Care Medicine

13 August 2017

1 reference

13 August 2017

176

1 reference

13 August 2017

1084-1089

1 reference

13 August 2017

11

1 reference

High-dose ibuprofen therapy associated with esophageal ulceration after pneumonectomy in a patient with cystic fibrosis: a case report

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176097

Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176097

Pyloric channel stricture secondary to high-dose ibuprofen therapy in a patient with cystic fibrosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176097

Changes in the normal maximal expiratory flow-volume curve with growth and aging

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176097

Effect of ibuprofen on neutrophil migration in vivo in cystic fibrosis and healthy subjects

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176097

Estimating effectiveness in an observational study: a case study of dornase alfa in cystic fibrosis. The Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176097

Transient renal failure due to simultaneous ibuprofen and aminoglycoside therapy in children with cystic fibrosis.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176097

Effect of high-dose ibuprofen in patients with cystic fibrosis.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176097

Renal failure and vestibular toxicity in an adolescent with cystic fibrosis receiving gentamicin and standard-dose ibuprofen

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176097

The use of anti-inflammatory medications in cystic fibrosis: trends and physician attitudes

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2176097

Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada

22 September 2018

1 reference

12 December 2020

Use of high-dose ibuprofen in a pediatric cystic fibrosis center

1 reference

12 December 2020

Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects

1 reference

12 December 2020

1 reference

12 December 2020

Identifying treatments that halt progression of pulmonary disease in cystic fibrosis

1 reference

12 December 2020

10.1164/RCCM.200702-181OC

Identifiers

DOI

1 reference

13 August 2017

1 reference

13 August 2017

1 reference